Trademark: 79296446
Word
IBVIS
Status
Registered
Status Code
700
Status Date
Tuesday, May 31, 2022
Serial Number
79296446
Registration Number
6741536
Registration Date
Tuesday, May 31, 2022
Mark Type
4000
Filing Date
Tuesday, August 11, 2020
Published for Opposition
Tuesday, March 15, 2022

Trademark Owner History
Veritas In Silico Inc. - Original Registrant

Classifications
42 Designing of machines, apparatus, instruments, machine parts, and systems composed of such machines, apparatus and instruments; pharmaceutical, medicine, chemical and engineering design services; computer software design, computer programming, and maintenance of computer software; designing, programming and maintenance of computer software having artificial intelligence functionality; computer software design, computer programming, and maintenance of computer software for use in scientific and technical analysis of data from artificial intelligence; computer software design, computer programming, and maintenance of computer software for use in analysis, testing, screening, designing, development or research on nucleic acids, pharmaceuticals or chemicals; computer software design, computer programming, and maintenance of computer software for use in drug discovery screening; computer software design, computer programming, and maintenance of computer software for analyzing and assaying messenger RNA (mRNA) substructures; computer program design, computer programming, and maintenance of computer program for databases; computer software design, computer programming, and maintenance of computer software for use in genome research or the development of consumer health products, treatments, pharmaceutical preparations, diagnostic instruments or foodstuffs; information processing using computers, namely, providing online nondownloadable software for processing of data regarding RNA and RNA-compound interaction by computers for use in developing new drugs; technical advice relating to computers, computers for automobiles and other computers for industrial machines requiring highly specialized knowledge, skills and experiences for proper operation; scientific and technical research consultancy in the field of life information science, nucleic acids diagnosis and drug discovery, and research and development relating thereto; analysis and research in the field of life information science and technology, namely, analysis and research on target identification and validation, and prediction of structure and function of proteins and nucleic acids; laboratory research and development of new products for others in the field of life information science, nucleic acids diagnosis and drug discovery; scientific and technological services, namely, biochemical and biological testing, inspection of medical and chemical goods for quality control purposes, efficacy and quality analysis of medical and chemical products, medical and chemical product development and research; chemical analysis and screening on chemicals, namely, chemical product quality evaluation; screening on pharmaceuticals, namely, pharmaceutical product evaluation; scientific research, testing and analysis in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicines, chemicals and engineering; research services in the field of biological science, namely, isolation, purification, analysis, screening and research on DNA, RNA and other biological materials; quality assessment services, namely, quality control and evaluation for others; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; development and research on pharmaceuticals targeting messenger RNA (mRNA) substructures, and providing information and consultancy relating thereto; Scientific and technological services, namely, testing, inspection, analysis, surveying, development and research on small molecule compounds, antisense oligonucleotides and compounds, and providing information and consultancy relating thereto; analysis, surveying and development of pharmaceuticals, and providing information and consultancy relating thereto; testing, inspection and research for drug development and medical research purposes, and providing information and consultancy relating thereto; testing and research on biotechnology and providing information and consultancy relating thereto; medical and biological research in the nature of genomic experiments, analyses, research, assays, testing, inspection and detection of medical and biological products for efficacy and quality evaluation; consultancy, advice and providing information on medical and biological research in the nature of genomic experiments, analyses, research, assays, testing, inspection and detection of medical and biological products for efficacy and quality evaluation; testing, surveying, research and data analysis for research purposes in the field of biomedicine, genome biology, pharmacogenomics, diagnostics, clinical trials or bioengineering; testing, inspection and research of chemicals or reagents; research and development of vaccines and medicines; research and development of vaccines and medicines; consultancy and providing information on testing, inspection and research of pharmaceuticals, chemicals, reagents, cosmetics or foodstuffs; conducting clinical trials for others on pharmaceuticals; research on building construction or city planning; testing or research on prevention of pollution; testing or research on electricity; testing or research on civil engineering; testing, inspection or research on agriculture, livestock breeding or fisheries; testing the functionality of and research on machines, apparatus and instruments; rental of measuring apparatus; rental of computers; providing computer programs on data networks, namely, providing temporary use of non-downloadable computer software for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; cloud computing, namely, providing temporary use of on-line non-downloadable cloud computing software for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; software as a service (SaaS) services featuring software for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; electronic storage services for archiving electronic data; providing electronic data server storage services on the internet; providing temporary use of non-downloadable computer software having artificial intelligence functionality on data networks for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; providing temporary use of online non-downloadable computer software for analysis of science and technology data based on artificial intelligence (AI) technology; providing temporary use of online non-downloadable computer software for use in analysis, testing, screening, designing, development or research of nucleic acids, pharmaceuticals or chemicals; providing temporary use of online non-downloadable computer software for use in drug discovery screening; providing temporary use of online non-downloadable computer programs on data networks for analyzing and assaying messenger RNA, or mRNA, substructures; providing temporary use of online non-downloadable computer programs for creating, accessing, managing and searching databases; providing temporary use of online non-downloadable computer software for use in genome research and the development of consumer health products, treatments, pharmaceutical preparations, diagnostic instruments or foodstuffs; rental of laboratory apparatus and instruments

Trademark Events
Oct 11, 2022
Teas Change Of Correspondence Received
Oct 11, 2022
Teas Change Of Domestic Representatives Address
Oct 11, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 11, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 10, 2022
Final Decision Transaction Processed By Ib
Sep 15, 2022
Final Disposition Notice Sent To Ib
Sep 15, 2022
Final Disposition Processed
Aug 31, 2022
Final Disposition Notice Created, To Be Sent To Ib
May 31, 2022
Notice Of Registration Confirmation Emailed
May 31, 2022
Registered-Principal Register
Apr 10, 2022
Notification Of Possible Opposition - Processed By Ib
Mar 23, 2022
Notification Of Possible Opposition Sent To Ib
Mar 23, 2022
Notification Of Possible Opposition Created, To Be Sent To Ib
Mar 21, 2022
Notification Processed By Ib
Mar 15, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 15, 2022
Published For Opposition
Feb 23, 2022
Notification Of Possible Opposition Sent To Ib
Feb 23, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 23, 2022
Notification Of Notice Of Publication E-Mailed
Feb 6, 2022
Assigned To Lie
Feb 4, 2022
Approved For Pub - Principal Register
Feb 4, 2022
Examiner's Amendment Entered
Feb 4, 2022
Notification Of Examiners Amendment E-Mailed
Feb 4, 2022
Examiners Amendment E-Mailed
Feb 4, 2022
Examiners Amendment -Written
Jan 7, 2022
Teas/Email Correspondence Entered
Jan 7, 2022
Correspondence Received In Law Office
Jan 7, 2022
Teas Response To Office Action Received
Jul 27, 2021
Notification Of Priority Action E-Mailed
Jul 27, 2021
Priority Action E-Mailed
Jul 27, 2021
Priority Action Written
Jun 23, 2021
Teas/Email Correspondence Entered
Jun 23, 2021
Correspondence Received In Law Office
Jun 23, 2021
Teas Response To Office Action Received
Jan 15, 2021
Refusal Processed By Ib
Dec 29, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Dec 28, 2020
Refusal Processed By Mpu
Dec 15, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Dec 14, 2020
Non-Final Action Written
Dec 6, 2020
Assigned To Examiner
Oct 30, 2020
Application Filing Receipt Mailed
Oct 26, 2020
New Application Office Supplied Data Entered In Tram
Oct 22, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24